Kazia Therapeutics (KZIA) Other Non-Current Liabilities (2009 - 2025)

Kazia Therapeutics' Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $5047.1 for Q4 2025.

• Quarterly Other Non-Current Liabilities fell 99.78% year-over-year to $5047.1 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5047.1 (down 99.78% YoY) and the FY2025 annual result came in at $4923.0, down 99.8% from the prior year.
• Other Non-Current Liabilities was $5047.1 for Q4 2025 at Kazia Therapeutics, up from $4923.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $5.9 million in Q2 2022 and bottomed at $4923.0 in Q2 2025.
• A 5-year average of $2.7 million and a median of $2.5 million in 2021 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities soared 838.8% — and 2025, when it sank 99.8%.
• Kazia Therapeutics' Other Non-Current Liabilities stood at $568165.0 in 2021, then surged by 838.8% to $5.3 million in 2022, then plunged by 32.14% to $3.6 million in 2023, then sank by 36.49% to $2.3 million in 2024, then plunged by 99.78% to $5047.1 in 2025.
• Business Quant data shows KZIA's Other Non-Current Liabilities at $5047.1 in Q4 2025, $4923.0 in Q2 2025, and $2.3 million in Q4 2024.